📌 Key Takeaways
- Topic: Silica as a Toothpaste Abrasive: How It Cleans and How RDA Is Controlled
- Keywords: silica vs silicone
- Published: 2026-11-20 00:55:53
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Aerogel Insulation: Thermal Performance, Uses and Cost Comparison
- Cosmetic Grade Silica: Types, Benefits and Uses in Skincare and Makeup
- Xiong, Y., Zhang, Y., Zhou, C. & Yu, T. ROS scavenging Manganese-loaded mesoporous silica nanozymes for catalytic anti-inflammatory therapy. Adv. Powder Technol. 34, 103886 (2023). Post CAS Google Scholar
- Colloidal Silica Slurry: Specifications and Uses in CMP and Precision Polishing
- Kayani, Z. et al. Combating cancer by utilizing noble metallic nanostructures in combination with laser photothermal and X-ray radiotherapy. J. Drug Deliv. Sci. Technol. 65, 102689 (2021). Article CAS Google Scholar
- Matting Agent Supplier: How to Choose the Right Silica Matting Agent Partner
- Dong, S. et al. Engineered design of a mesoporous silica nanoparticle-based nanocarrier for productive mRNA delivery in vivo. Nano Lett. 23, 2137-2147 (2023). Post CAS PubMed Google Scholar
- 5N Quartz Sand: Purity Specifications, Key Impurities and High-Tech Applications
Silica Powder Price: What Determines Cost and Typical Price Ranges
What is silica (SiO₂)?
silica for refractory Vallet‐Regí, M., Balas, F. & Arcos, D. Mesoporous materials for drug delivery. Angew. Chem. Int. Ed. 46, 7548-7558 (2007). Article Google Scholar
What is the difference between fumed silica and precipitated silica?
silica gel manufacturer Along with targeted ligand, cell membrane-based biomimetic strategy is also a current and really feasible approach to enhance the targeting skill of MSNs (Fig. 6b ). The cell membrane biomimetic method dates back to 2011, when Zhang's group used intact red blood cell membranes to encapsulate NPs via a top-down strategy. Compared with unencapsulated NPs, NPs encapsulated by red blood cell membranes have a longer half-life in mice and remain in circulation for up to 72 h due to the immune escape function possessed by the cell membrane. 326 The preparation process is typically divided into three steps: membrane extraction, preparation of inner core NPs, and fusion of membrane and NPs. The cell membrane-coated NPs combine the benefits of outer cells and inner core NPs, and achieve long-term in vivo circulation and targeted delivery while greatly improving biocompatibility. 327 The therapeutic potential of diverse types of cell membranes-engineered MSNs-based drug delivery systems has been demonstrated in a variety of disease models. For example, platelet membrane-coated MSNs were used for early atherosclerosis therapy by mimicking the immune escape ability of platelet. 328 Cancer cell membrane-coated MSNs were specifically enriched in tumor sites by homologous targeting properties, and activated the ferroptosis-related immunogenic cell death on gastric cancer. 329 Bacterial outer membrane-coated MSNs are used for targeted delivery of the antibiotic rifampicin to achieve in vivo resistance to gram-negative bacterial infections. 330 Despite the limitations of current research related to cell membrane biomimetic tactic, these instances invariably show the effectiveness of cell membrane-based active targeting strategy in enhancing the targeting ability and therapeutic efficacy of MSNs.
What drives silica raw material prices?
silica melting point Considering these components, substantial efforts have been conducted to go for particular surface functionalization modifications of MSNs to decrease their toxicity such as neurotoxicity, immunotoxicity, and systemic toxicity (Fig. 6a ). A common approach is to integrate the biocompatible polymers with MSNs. Polymers including polyethylene glycol (PEG), polyethylenimine (PEI) and chitosan have been demonstrated to be excellent surface coating agents for MSNs, which can substantially enhance the in vivo circulation time, decrease cytotoxicity and hemolytic effect of MSNs. 295, 296, 297, 298 In terms of decreasing protein adsorption and boosting the colloidal stability of the particles, PEG is at present considered as an extremely excellent polymer. 298, 299, 300 Hao et al. systematically investigated the hemolytic activity and protein adsorption behavior of bare MSNs, MSNs modified with chitosan (MSNs-CS) and MSNs co-modified with chitosan and PEG (MSNs-CS-PEG). 301 Results showed that the hemolysis percentage and protein adsorption of MSNs-CS-PEG were 2% and 3.2%, respectively, which were remarkably lower than those of bare MSNs (30.9% and 14.5%, respectively), and they also exhibited lower toxicity toward MCF-7 cells. 301 This was similarly demonstrated in a study by He et al. 302 As well as polymers, liposomes have the advantages of high biocompatibility, low immunogenicity and long circulation, thereby they can also be used to enhance the biosafety of MSNs. 303, 304, 305 MSNs can be encapsulated by lipid bilayers or multilayers, and these liposomes act as protective shells to reduce toxicity by masking the reactive groups on the surface of MSNs. Compared to bare MSNs, liposome-encapsulated MSNs exhibit superior particle dispersion and lower non-specific binding. 306, 307 Additionally, they lead to the higher bioavailability and the in vivo half-life can be prolonged more than 10-fold, reducing the distribution of MSNs in reticuloendothelial system (RES)-related organs. 306 Protein coating is also a way to boost the biocompatibility and particle stability of MSNs. 308, 309 Negatively charged bull serum albumin (BSA), which is highly physiologically stable during blood circulation, can tightly bind to the amino groups on the MSNs surface, preventing the premature release of drug loaded on the MSNs. 309 Apart from, given that the positively charged MSNs show significant toxicity influence, some researchers have devoted to regulating the surface properties of MSNs by direct group modification. The surface potential of MSNs can be regulated by diverse functionalization via carboxyl (-COOH), phenyl (-Ph), and methyl phosphonate (-PO 3 - ) groups with negative and neutral zeta potentials. 310, 311
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.